Watch the oxycodone Results-at-a-Glance video summary.
This video version of the oxycodone Results-at-a-Glance summary features iCAN member Adhiti.
Resources
Diazepam Results-at-a-Glance Video
Watch the diazepam Results-at-a-Glance summary video.
This video version of the diazepam Results-at-a-Glance summary features iCAN member Krisha.
Rifampin Results-at-a-Glance Video
Watch the rifampin Results-at-a-Glance summary video.
This video version of the rifampin Results-at-a-Glance summary features iCAN member Adhiti.
Lisinopril Results-at-a-Glance video
Watch the lisinopril Results-at-a-Glance video summary.
This video version of the lisinopril Results-at-a-Glance summary features iCAN member Luke.
Meropenem Results-at-a-Glance video
Watch the meropenem Results-at-a-Glance video summary.
This video version of the meropenem Results-at-a-Glance summary features iCAN member Arthur.
Caffeine Citrate Results-at-a-Glance video
Watch the caffeine citrate Results-at-a-Glance video summary.
This video version of the caffeine citrate Results-at-a-Glance summary features iCAN member Meghan.
babyTAPE Results-at-a-Glance video
Watch the babyTAPE Results-at-a-Glance video summary.
This video version of the babyTAPE Results-at-a-Glance summary features iCAN member Katherine.
PTN Publications Policy Version 5.0
View the Publications Policy Version 5.0.
This PTN Publications Policy applies to information that represents PTN, is supported by PTN, or uses data provided by PTN. Examples of such information includes PTN Publications such as abstracts, manuscripts, slide decks, and texts of oral or other presentations. Additionally, this information can be PTN Public Presentations, such as text for social media or public-facing websites.
Lorazepam Results-at-a-Glance
Read the lorazepam Results-at-a-Glance summary.
Status epilepticus (SE) is a serious condition that affects the brain. SE can be caused by medical conditions, illnesses, or injuries. A preferred treatment for SE is lorazepam. However, lorazepam is not approved by the FDA for children under 18 years old. This summary is for a study performed by the Pediatric Trials Network (PTN). The study was needed to find out how children with SE process lorazepam.
Oxcarbazepine Results-at-a-Glance
Read the oxcarbazepine Results-at-a-Glance summary.
Oxcarbazepine is a medicine that is approved by the U.S. Food and Drug Administration (FDA) for treating seizures in adults and children older than two years. However, guidance for children who have obesity was lacking. This study was needed to learn how a child’s obesity status affects the way they process oxcarbazepine.